Acquired EML4-ALK fusion and EGFR C797S in cis mutation as resistance mechanisms to osimertinib in a non-small cell lung cancer patient with EGFR L858R/T790M.
| Autor: | Liang-Sheng Wang, Shi-Qi Chen, Xue Zhong, Xiao-Dong Jiao, Ke Liu, Bao-Dong Qin, Ying Wu, Yan Ling, Xiao-Peng Duan, Yuan-Sheng Zang |
|---|---|
| Zdroj: | Anti-Cancer Drugs; Nov2023, Vol. 34 Issue 10, p1146-1150, 5p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|